1. Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.

    Oncotarget 6(31):31493 (2015) PMID 26372814 PMCID PMC4741620

    Epigenetic silencing of tumor suppressor genes (TSGs) by promoter methylation can be an early event in the multi-step process of carcinogenesis. Human chromosome 3 contains clusters of TSGs involved in many cancer types including nasopharyngeal carcinoma (NPC), the most common cancer in Southern...
  2. D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.

    Tumor Biology 35(4):3237 (2014) PMID 24264315

    D-glucuronyl C5-epimerase (GLCE) is involved in breast and lung carcinogenesis as a potential tumor suppressor gene, acting through inhibition of tumor angiogenesis and invasion/metastasis pathways. However, in prostate tumors, increased GLCE expression is associated with advanced disease, sugge...
  3. Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.

    Cancer Medicine 2(5):654 (2013) PMID 24403231 PMCID PMC3892797

    Heparansulfate proteoglycans (HSPG) play an important role in cell-cell and cell-matrix interactions and signaling, and one of the key enzymes in heparansulfate biosynthesis is d-glucuronyl C5-epimerase (GLCE). A tumor suppressor function has been demonstrated for GLCE in breast and lung carcino...
  4. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

    Epigenetics 8(4):409 (2013) PMID 23478628 PMCID PMC3674050

    Genetic and epigenetic alterations in cervical carcinomas were investigated using NotI-microarrays containing 180 cloned sequences flanking all NotI-sites associated with genes on chromosome 3. In total, 48 paired normal/tumor DNA samples, specifically enriched in NotI-sites, were hybridized to ...
  5. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma.

    Cancer Letters 325(1):89 (2012) PMID 22743615

    This study identified LTBP-2 as a pleiotropic tumor suppressor in nasopharyngeal carcinoma, which safeguards against critical malignant behaviors of tumor cells. LTBP-2 expression was significantly decreased or lost in up to 100% of NPC cell lines (7/7) and 80% of biopsies (24/30). Promoter hype...
  6. miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues.

    Epigenetics 7(10):1109 (2012) PMID 22968430 PMCID PMC3469452

    microRNAs (miRNAs) are key posttranscriptional regulators of gene expression. In the present study, regulation of tumor-suppressor gene D-glucuronyl C5-epimerase (GLCE) by miRNA-218 was investigated. Significant downregulation of miRNA-218 expression was shown in primary breast tumors. Exogenous...
  7. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.

    Epigenetics 7(8):930 (2012) PMID 22805760 PMCID PMC3427288

    D-glucuronyl C5-epimerase (GLCE) is a potential tumor-suppressor gene involved in heparan sulfate biosynthesis. GLCE expression is significantly decreased in breast tumors; however, the underlying molecular mechanisms remain unclear. This study examined the possible epigenetic mechanisms for GLC...
  8. LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.

    Biochimie 94(5):1151 (2012) PMID 22321817

    Chromosome 3 specific NotI microarrays containing 180 NotI linking clones associated with 188 genes were hybridized to NotI representation probes prepared using matched tumor/normal samples from major epithelial cancers: breast (47 pairs), lung (40 pairs) cervical (43 pairs), kidney (34 pairs of...
  9. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

    Epigenetics 7(5):502 (2012) PMID 22491060

    This study aimed to clarify genetic and epigenetic alterations that occur during lung carcinogenesis and to design perspective sets of newly identified biomarkers. The original method includes chromosome 3 specific NotI-microarrays containing 180 NotI clones associated with genes for hybridizati...
  10. Alterations of the WNT7A gene in clear cell renal cell carcinomas.

    PLoS ONE 7(10):e47012 (2012) PMID 23056560 PMCID PMC3466251

    WNT7A (wingless-type MMTV integration site family, member 7A) is a known tumor suppressor gene of non-small cell lung carcinomas (NSCLC) and is frequently inactivated due to CpG-island hypermethylation in human cancers. The members of WNT family are involved in cell signaling and play crucial ro...
  11. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.

    International Journal of Cancer 130(1):83 (2012) PMID 21387288

    Suppressive effects of DUSP6 in tumorigenesis and EMT-associated properties were observed. Dual-specificity phosphatase (DUSP6) is a MAP kinase phosphatase (MKP) negatively regulating the activity of ERK, one of the major molecular switches in the MAPK signaling cascade propagating the signaling...
  12. Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma.

    International Journal of Cancer 129(8):1826 (2011) PMID 21165953

    The association of Matrix metalloproteinase-19 (MMP19) in the development of nasopharyngeal carcinoma (NPC) was identified from differential gene profiling, which showed MMP19 was one of the candidate genes down-regulated in the NPC cell lines. In this study, quantitative RT-PCR and Western blot...
  13. Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors.

    Cell Adhesion & Migration 5(5):395 (2011) PMID 21975548 PMCID PMC3218606

    Integrin alpha9 (ITGA9) is one of the less studied integrin subunits that facilitates accelerated cell migration and regulates diverse biological functions such as angiogenesis, lymphangiogenesis, cancer cell proliferation and migration. In this work, integrin alpha9 expression and its epigeneti...
  14. Cloning and Initial Functional Characterization of Mlk4α and Mlk4β.

    Genomics Insights 4:1 (2011) PMID 26217104 PMCID PMC4510602

    We have cloned a novel human mixed-lineage kinase gene, MLK4. Two alternatively spliced forms, MLK4α (580 aa) and MLK4β (1036 aa), have been identified and mapped to chromosomal band 1q42. MLK4 shows high amino acid homology to the kinase catalytic domain of MLK3 (72%), MLK1 (71%) and MLK2 (69%)...
  15. Differential expression of CHL1 gene during development of major human cancers.

    PLoS ONE 6(3):e15612 (2011) PMID 21408220 PMCID PMC3049765

    CHL1 gene (also known as CALL) on 3p26.3 encodes a one-pass trans-membrane cell adhesion molecule (CAM). Previously CAMs of this type, including L1, were shown to be involved in cancer growth and metastasis. We used Clontech Cancer Profiling Arrays (19 different types of cancers, 395 samples) to...
  16. Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.

    International Journal of Cancer 127(2):304 (2010) PMID 19921696

    THY1 was previously identified as a candidate tumor suppressor gene (TSG) associated with lymph node metastases in nasopharyngeal carcinoma (NPC) through functional studies. It was identified by oligonucleotide microarray analysis as an interesting differentially expressed gene. However, direct ...
  17. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.

    Cancer Research 70(13):5567 (2010) PMID 20551050 PMCID PMC2896444

    ADAMTS metalloprotease family member ADAMTS9 maps to 3p14.2 and shows significant associations with the aerodigestive tract cancers esophageal squamous cell carcinoma (ESCC) and nasopharyngeal carcinoma (NPC). However, the functional impact of ADAMTS9 on cancer development has not been explored....
  18. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.

    Cancer Science 101(6):1511 (2010) PMID 20412120

    To understand the association between candidate tumor suppressor genes (TSGs) human mismatch repair protein homologue 1 (hMLH1), AP20 region gene 1 (APRG1), integrin alpha RLC (ITGA9), RB1 serine phosphates from human chromosome 3 (RBSP3) at chromosomal 3p22.3 region and development of head and ...
  19. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.

    Genes, Chromosomes and Cancer 49(2):155 (2010) PMID 19885927

    To understand the importance of frequent deletion of 3p22.3 in cervical carcinogenesis, alterations (deletion/methylation/expression) of the candidate genes STAC, MLH1, ITGA9, and RBSP3, located in the region, were analyzed in 24 cervical intraepithelial neoplasia (CIN) and 137 uterine cervical ...
  20. Antiproliferative effect of D-glucuronyl C5-epimerase in human breast cancer cells.

    Cancer Cell International 10:27 (2010) PMID 20723247 PMCID PMC2936283

    D-glucuronyl C5-epimerase (GLCE) is one of the key enzymes in the biosynthesis of heparansulfate proteoglycans. Down-regulation of GLCE expression in human breast tumours suggests a possible involvement of the gene in carcinogenesis. In this study, an effect of GLCE ectopic expression on cell pr...